Femasys Inc.
About Femasys Inc.
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Senior Secured Convertible Notes T: - FT: Senior Secured Convertible Notes |
A: 12000000 MR: - FA: 12 million FAN: 12000000 |
D: 2025-11-03 FD: 2025-11-03 |
1 investors |
| 2 |
RT: Financing T: - FT: Financing |
A: 8000000 MR: - FA: 8 million FAN: 8000000 |
D: 2025-09-02 FD: 2025-09-02 |
1 investors |
| 3 |
RT: Underwritten Public Offering T: - FT: Underwritten Public Offering |
A: 8000000 MR: - FA: $8.0 Million FAN: 8000000 |
D: 2025-08-25 FD: 2025-08-25 |
2 investors |
| 4 |
RT: Underwritten Public Offering and Concurrent Private Placement T: - FT: Underwritten Public Offering and Concurrent Private Placement |
A: 4500000 MR: - FA: $4.5 million FAN: 4500000 |
D: 2025-05-30 FD: 2025-05-30 |
2 investors |
| 5 |
RT: Senior unsecured convertible note T: - FT: Senior unsecured convertible note |
A: 6850000 MR: - FA: 6.85 million FAN: 6850000 |
D: 2023-11-15 FD: 2023-11-15 |
2 investors |
| 6 |
RT: Registered Direct Offering T: - FT: Registered Direct Offering |
A: 3900000 MR: - FA: 3.9 million FAN: 3900000 |
D: 2023-04-19 FD: 2023-04-19 |
- |
Growth Metrics
Team & Leadership
Kathy Lee-Sepsick
President and Chief Executive Officer (Founder)
Dov Elefant
Chief Financial Officer
James H. Liu
Chief Medical Officer
Daniel Currie
Chief Operating Officer
Christine Thomas
Chief Regulatory & Clinical Officer
Mary An Merchant
Vice President Counsel, Intellectual Property
Recent News
Femasys Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- femasys.com
- Industries
- Biomedical / Women's Health
- Company Size
- ~400 employees (est.)
- Locations
-
Atlanta, USA
Atlanta
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro